EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+1.88%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$6.75B
AUM Growth
+$6.75B
(+4.6%)
Cap. Flow
+$463M
Cap. Flow
% of AUM
6.86%
Top 10 Holdings %
Top 10 Hldgs %
24.03%
Holding
179
New
20
Increased
67
Reduced
21
Closed
18
Top Buys
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$65.6M |
| 2 |
Entegris
ENTG
|
$60.2M |
| 3 |
TSMC
TSM
|
$50.5M |
| 4 |
Cullinan Oncology
CGEM
|
$49M |
| 5 |
Zymeworks
ZYME
|
$44.1M |
Top Sells
| 1 |
Ecolab
ECL
|
$49.8M |
| 2 |
Wayfair
W
|
$49M |
| 3 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$41.8M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$23.8M |
| 5 |
CrowdStrike
CRWD
|
$20.3M |
Sector Composition
| 1 | Healthcare | 40.17% |
| 2 | Technology | 26.2% |
| 3 | Industrials | 11.22% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Communication Services | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
76
DELISTED
ChemoCentryx, Inc.
CCXI
| $28.7M | 0.43% |
560,000
+173,000
| +45% | +$8.86M |
|
|
SMAR
77
DELISTED
Smartsheet Inc.
SMAR
| $27.9M | 0.41% |
437,000
| – | – |
|
78
XPO
XPO
$14.8B
| $27.1M | 0.4% |
220,000
| – | – |
|
79
Skyworks Solutions
SWKS
$10.9B
| $27.1M | 0.4% |
147,547
-33,000
| -18% | -$6.05M |
|
80
Xenon Pharmaceuticals
XENE
$2.99B
| $26.7M | 0.4% |
1,490,000
+459,860
| +45% | +$8.23M |
|
81
Keros Therapeutics
KROS
$640M
| $26.3M | 0.39% |
427,414
+81,414
| +24% | +$5.01M |
|
82
Monolithic Power Systems
MPWR
$39.6B
| $26.2M | 0.39% |
74,159
+1,300
| +2% | +$459K |
|
83
Rollins
ROL
$27.3B
| $25M | 0.37% |
727,500
| – | – |
|
84
Okta
OKTA
$15.8B
| $23.8M | 0.35% |
108,000
| – | – |
|
85
MongoDB
MDB
$25.5B
| $23.8M | 0.35% |
88,980
| – | – |
|
86
KALA BIO
KALA
$105M
| $23.3M | 0.34% |
3,450,000
| – | – |
|
87
Repligen
RGEN
$6.54B
| $23.1M | 0.34% |
119,000
| – | – |
|
88
Phathom Pharmaceuticals
PHAT
$843M
| $22.5M | 0.33% |
600,000
| – | – |
|
89
ADC Therapeutics
ADCT
$370M
| $22.3M | 0.33% |
914,739
-160,261
| -15% | -$3.91M |
|
|
MRTX
90
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $22.2M | 0.33% |
129,471
| – | – |
|
91
Xencor
XNCR
$594M
| $21.8M | 0.32% |
506,000
| – | – |
|
92
Sotera Health
SHC
$4.54B
| $21.7M | 0.32% |
870,000
| – | – |
|
93
Beyond Meat
BYND
$178M
| $19.9M | 0.29% |
+152,593
| New | +$19.9M |
|
|
XLRN
94
DELISTED
Acceleron Pharma Inc.
XLRN
| $19.4M | 0.29% |
142,900
| – | – |
|
95
Butterfly Network
BFLY
$378M
| $18.8M | 0.28% |
1,118,000
| – | – |
|
96
Intuitive Surgical
ISRG
$158B
| $18.5M | 0.27% |
25,000
| – | – |
|
|
FRC
97
DELISTED
First Republic Bank
FRC
| $16.5M | 0.25% |
99,200
+34,900
| +54% | +$5.82M |
|
98
Cardiff Oncology
CRDF
$130M
| $16.5M | 0.24% |
+1,783,488
| New | +$16.5M |
|
99
ARS Pharmaceuticals
SPRY
$1.08B
| $16.2M | 0.24% |
371,384
+29,911
| +9% | +$1.3M |
|
100
908 Devices
MASS
$199M
| $16.2M | 0.24% |
333,283
| – | – |
|